CBD distillate 85% for formulation-ready cannabinoid products.

CBD Distillate 85% from Cilo Cybin's GMP cannabinoid API portfolio: 85% CBD specification target, golden amber refined oil, and formulation-ready documentation.

This page provides supporting information about Cilo Cybin's company platform, products, services, and stakeholder communications.

A refined CBD distillate for licensed manufacturers that need an oil-format CBD input with higher potency, cleaner handling, and batch-level documentation.

CBD Distillate 85% is a refined amber oil for licensed manufacturers that need a higher-potency CBD input with retained minor cannabinoids and oil-phase handling. The target profile is ≥85% CBD, ≥1.5% minor cannabinoids, and a ≤0.01% THC target.

This product is appropriate where a formulation needs a potent CBD oil rather than a powder isolate. Compare with CBD Isolate for neutral single-cannabinoid precision, CBD CRD for crystallisation resistance, and CBD Crude 70%+ where downstream processing flexibility is required.

Use these pages to move between adjacent products without losing the family context.

Send the Cilo Cybin team your target format, desired specification, estimated volume, destination market, and documentation requirements.

Pharmaceutical biotechnology for regulated cannabinoid API's, bulk products, finished formats, and partner supply programs.

For partnership, product, or company enquiries, contact Cilo Cybin for the latest approved information.